ROBO Global Healthcare Technology and Innovation ETF Rating $29.06 -0.82 (-2.74%) (As of 03:07 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings ROBO Global Healthcare Technology and Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HTEC Aggregate RatingModerate Buy 2.59Holdings in HTEC have an aggregate rating of Moderate Buy based on 616 analyst ratings issued in the past year covering 45 companies (71.9% of the portfolio).HTEC Aggregate Price Target$29.06High Prediction$29.06Average Prediction$29.06Low Prediction$29.06Holdings in HTEC have an aggregate price target of $29.06 and a range of $29.06 to $29.06 covering 45 companies (71.9% of the portfolio).HTEC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce3 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ROBO Global Healthcare Technology and Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 HTEC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.56%GHGuardant Health$33.13-4.9%3.9028 of 5 stars3.00$40.60 22.5%152.50%NTRANatera$159.22-5.3%2.3086 of 5 stars3.00$152.67 -4.1%152.29%NVCRNovoCure$32.04-0.2%2.8808 of 5 stars2.67$32.67 2.0%61.94%VCYTVeracyte$40.58-3.9%4.1712 of 5 stars2.67$41.13 1.3%91.92%ISRGIntuitive Surgical$535.76-1.7%4.765 of 5 stars2.74$554.17 3.4%19Analyst ForecastPositive News1.88%AXGNAxoGen$14.48-1.8%1.0582 of 5 stars3.00$15.00 3.6%4Positive News1.84%PENPenumbra$242.42-2.1%4.2739 of 5 stars2.80$258.00 6.4%15Analyst Forecast1.79%GRALGrail$19.18-18.8%0.4571 of 5 stars2.00$16.00 -16.6%31.79%ILMNIllumina$135.25-5.5%4.4403 of 5 stars2.70$165.95 22.7%20Short Interest ↑1.79%TWSTTwist Bioscience$45.38-6.2%3.0378 of 5 stars2.70$51.90 14.4%101.77%BSXBoston Scientific$89.23-1.3%4.5314 of 5 stars2.91$95.96 7.5%23Analyst ForecastShort Interest ↑1.77%SYKStryker$364.35-1.7%4.9784 of 5 stars2.85$405.80 11.4%20Analyst ForecastPositive News1.75%INCYIncyte$68.19-1.7%4.8122 of 5 stars2.35$76.18 11.7%20Analyst Forecast1.73%DNAGinkgo Bioworks$8.82-8.2%0.6259 of 5 stars1.60$4.58 -48.1%5News Coverage1.70%CRSPCRISPR Therapeutics$41.45-7.1%1.9212 of 5 stars2.44$77.93 88.0%18Short Interest ↓1.70%MASIMasimo$172.68-0.8%4.0673 of 5 stars2.71$175.67 1.7%7Analyst Forecast1.68%CRLCharles River Laboratories International$185.22-2.2%4.6361 of 5 stars1.93$214.00 15.5%15Positive News1.63%VRTXVertex Pharmaceuticals$450.07-4.1%4.5876 of 5 stars2.55$505.73 12.4%31Analyst ForecastPositive News1.63%AORTArtivion$27.96-3.3%2.3435 of 5 stars3.00$31.80 13.7%51.61%ARWRArrowhead Pharmaceuticals$20.79-6.6%4.3753 of 5 stars2.64$42.70 105.4%11Short Interest ↑Analyst Revision1.59%IRTCiRhythm Technologies$87.19-4.7%3.2076 of 5 stars2.82$109.27 25.3%11Analyst Forecast1.59%RVTYRevvity$110.74-3.5%3.9647 of 5 stars2.75$132.47 19.6%16Positive News1.57%CTLTCatalent$63.482.7842 of 5 stars2.00$63.40 -0.1%7Trading HaltedHigh Trading Volume1.52%EWEdwards Lifesciences$73.20-1.2%3.9974 of 5 stars2.42$79.40 8.5%26Analyst UpgradeInsider TradeAnalyst Revision1.43%AAgilent Technologies$134.59-1.4%4.7561 of 5 stars2.43$143.62 6.7%14Short Interest ↓Analyst Revision1.43%MEDPMedpace$339.82-2.5%4.3865 of 5 stars2.45$380.56 12.0%111.42%DHRDanaher$231.22-1.0%4.8534 of 5 stars2.79$287.95 24.5%19Short Interest ↑Analyst Revision1.42%TMOThermo Fisher Scientific$521.27-1.4%4.8616 of 5 stars2.86$652.30 25.1%21Analyst RevisionPositive News1.42%BMYBristol-Myers Squibb$57.30-0.6%4.8158 of 5 stars2.25$55.64 -2.9%20Dividend IncreaseAnalyst UpgradePositive News1.38%QGENQiagen$44.30-2.3%4.2266 of 5 stars2.60$51.15 15.5%101.38%ALGNAlign Technology$216.88-5.2%4.8039 of 5 stars2.33$271.20 25.0%121.37%ABTAbbott Laboratories$113.01-0.2%4.9158 of 5 stars2.73$130.71 15.7%15Dividend Increase1.36%GKOSGlaukos$145.34-0.7%4.1552 of 5 stars2.85$145.92 0.4%13Analyst ForecastShort Interest ↓1.36%IARTIntegra LifeSciences$22.55-2.1%4.1663 of 5 stars1.75$23.00 2.0%8Positive News1.36%TEMTempus AI$35.56-8.7%2.8734 of 5 stars2.75$56.00 57.5%12High Trading Volume1.34%DXCMDexCom$76.05-2.2%4.991 of 5 stars2.72$98.00 28.9%18Short Interest ↓1.34%NOVTNovanta$158.49-4.3%2.629 of 5 stars2.00$169.00 6.6%1News CoveragePositive News1.33%AZTAAzenta$50.20+8.4%2.5661 of 5 stars2.60$61.60 22.7%5Analyst UpgradeGap Up1.33%GMEDGlobus Medical$83.49+0.1%4.9555 of 5 stars2.67$94.55 13.2%12Analyst ForecastShort Interest ↓Analyst Revision1.32%EXASExact Sciences$57.98-4.0%4.5467 of 5 stars2.94$72.94 25.8%181.29%OMCLOmnicell$45.06-0.3%3.1393 of 5 stars2.33$52.00 15.4%61.28%STAASTAAR Surgical$24.29-4.5%4.5832 of 5 stars2.33$42.83 76.3%91.27%UTHRUnited Therapeutics$359.05-5.4%4.7089 of 5 stars2.73$370.86 3.3%15Positive News1.26%IQVIQVIA$194.02-1.3%4.9214 of 5 stars2.90$256.19 32.0%20Short Interest ↓Analyst Revision1.25%VEEVVeeva Systems$223.20-1.4%4.8381 of 5 stars2.62$256.58 15.0%26Analyst ForecastPositive News This page (NYSEARCA:HTEC) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ROBO Global Healthcare Technology and Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ROBO Global Healthcare Technology and Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
